Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK
(marketscreener.com) VANCOUVER, British Columbia, Oct. 12, 2023 — Mydecine Innovations Group, Inc. , a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular empha…
VANCOUVER, British Columbia, Oct. 12, 2023 (GLOBE NEWSWIRE) — Mydecine Innovations Group, Inc. (Mydecine or the Company) (NEO:MYCO) (AQSE: MYIG) (OTC: MYCOF) (FSE: 0NFA), a biotechnology company eng…